Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices

Back

ESC Professional Premium Access

Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices

Session: Prognosis and outcome in patients with atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor G. Peigh (Chicago, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Graham Peigh

Northwestern University, Chicago (United States of America)

0 follower

7 more presentations in this session

Cigarette smoking and structural brain deficits in patients with atrial fibrillation

Speaker: Mr R. Peter (Basel, CH)

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)

Speaker: Miss J. Choi (Seoul, KR)

The current and future total health care costs of atrial fibrillation

Speaker: Doctor R. Sandhu (Los Angeles, US)

Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

Speaker: Doctor M. Kodali (Milwaukee, US)

Access

Abstract

Slides

Access the full session

Prognosis and outcome in patients with atrial fibrillation

Speakers: Doctor G. Peigh, Mr R. Peter, Miss J. Choi, Doctor R. Sandhu, Doctor A. Fawzy...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices

About the speaker

Doctor Graham Peigh

7 more presentations in this session

Cigarette smoking and structural brain deficits in patients with atrial fibrillation

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)

The current and future total health care costs of atrial fibrillation

Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population

Pulmonary hypertension is an adverse risk factor for peri-procedural complications in patients undergoing cardioversion for atrial fibrillation

Access the full session

Prognosis and outcome in patients with atrial fibrillation

About the event

ESC Congress 2023

ESC 365 is supported by